Clinical significance of fatty liver associated with metabolic syndrome

Hepatology Research

Volumn 37, Issue 9, 2007, Pages 711-721

  Kogiso, Tomomi ^a,c   Moriyoshi, Yuriko ^a   Nagahara, Hikaru ^b,c  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Fatty liver; High sensitivity C reactive protein; Insulin resistance; Menopause; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER BIAS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HEMOGLOBIN DETERMINATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 34447302825     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00116.x     Document Type: Article

References (38)

1. Association of Health and Welfare Statistics. Kokumin eiseinodoukou. Tokyo, Japan: Kokumineisei-kyokai, 2003.
2. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: Analysis of clinical background. Jpn J Gastroenterol 2003; 38: 954-61.
3. World Advertising Research Center. World Drink Trends, 2003. UK: World Advertising Research Center, 2003.
4. Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.
5. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
6. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
7. The Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-92.
8. Obesity. Preventing and Managing the Global Epidemic. Report of a WHO consultation, WHO Technical report Series 894. Geneva: WHO, 2000.
9. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9.
10. Bellentani S, Saccoccio G, Masutti F et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000; 132: 112-17.
11. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24: 349-62.
12. Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003; 134: 18-27.
13. Pouliot MC, Despres JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk factors in men and women. Am J Cardiol 1994; 73: 460-8.
14. Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men-waist/height ratio as a simple and useful predictor. Int J Obes 1995; 19: 585-9.
15. Hsieh SD, Yoshinaga H. Waist/height ratio as a simple predictor of coronary heart disease risk factors in women. Intern Med 1995; 34: 1147-52.
16. Han TS, van Leer EM, Seidell JCJ, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. BMJ 1995; 311: 1401-5.
17. Jabbar A, Irfanullah A, Akhter J, Miraza YK. Dyslipidemia and its relation with body mass index versus waist hip ratio. J Pak Med Assoc 1997; 47: 308-10.
18. Nakayama T, Tokunaga K, Shimomura I et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239-46.
19. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-9.
20. Stranges S, Dorn JM, Muti P et al. Body fat distribution, relative weight, and liver enzyme levels: A population-based study. Hepatology 2004; 39: 754-63.
21. Hanley AJ, Williams K, Wagenknecht LE et al. Elevation in markers of liver injury and risk of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes 2004; 53: 2623-32.
22. Goto T, Onuma T, Kakebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841-5.
23. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson WF. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study circulation. Circulation 2004; 110: 380-5.
24. Ridker PM, Hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
25. Kang ES, Kim HJ, Ahn CW et al. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Res Clin Pract 2005; 69: 151-9.
26. Lim S, Lee HK, Kimm KC et al. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population CRP as risk factor of metabolic syndrome. Diabetes Res Clin Pract 2005; 70: 126-33.
27. Santos AC, Lopes C, Guimaraes JT et al. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond) 2005; 29: 1452-6.
28. Marchesini G, Bugianesi F, Forlani G et al. Nonalcoholic fatty liver, steatohepatits, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
29. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome. Prevalence and determinants of a 'bright' liver echopattern. Ital J Gastroenterol Hepatol 1997; 29: 351-6.
30. Suzuki R, Watanabe S, Hirai Y et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 1993; 95: 309-14.
31. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-62.
32. Kotani K, Tokunaga K, Fujioka S et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes 1994; 18: 207-12.
33. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ. Menopause and hyperthalamic-pituitary sensitivity to estrogen. JAMA 2004; 292: 2991-6.
34. Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-8.
35. Block G, Jensen C, Dietrich M et al. Plasma C-reactive protein concentrations in active and passive smokers: Influence of antioxidant supplementation. J Am Coll Nutr 2004; 23: 141-7.
36. Park SH, Kim BI, Yun JW et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 2004; 19: 694-8.
37. Machado M, Cortez-Pinto H. Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care 2006; 9: 637-42.
38. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens. Diabet Med 2007; 24: 1-6.